Noxafil 300 MG Powder for Oral Suspension

RxCUI: 2558607
RxNorm name: Noxafil 300 MG Powder for Oral Suspension
Display name: Noxafil 300 MG Powder for Oral Suspension
Full name: Noxafil 300 MG Powder for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NOXAFIL	POSACONAZOLE	Merck Sharp & Dohme LLC	b073b082-7b57-4423-8c06-4fd4263d6f84	2026-02-13	Warnings, Adverse reactions	Exact identifier rxcui: 2558607

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b073b082-7b57-4423-8c06-4fd4263d6f84	Noxafil PowderMix 300 MG Powder for Oral Suspension [PSN] · posaconazole 300 MG Powder for Oral Suspension [Noxafil] [SBD] · Noxafil 300 MG Powder for Oral Suspension [SY]	3	56	These highlights do not include all the information needed to use NOXAFIL safely and effectively. See full prescribing information for NOXAFIL. NOXAFIL ® (posaconazole) injection, for intravenous use NOXAFIL ® (posaconazole) delayed-release tablets, for oral use NOXAFIL ® (posaconazole) oral suspension NOXAFIL ® POWDERMIX (posaconazole) for delayed-release oral suspension Initial U.S. Approval: 2006	20260213